At the Third International Summit on Human Genome Editing, held in March 2023 at the Francis Crick Institute in London, ...

Cynata Therapeutics (ASX:CYP) has had its induced pluripotent stem cell (iPSC) derived mesenchymal stem cell (MSCs) verified ...

1. Nature研究报道了一项关于工程化心肌 (EHM)移植治疗心力衰竭的新进展，成功在恒河猴模型中实现长期移植物存留并增强目标心室壁收缩功能。 2. 该研究利用诱导多能干细胞 ...

Muscle patches generated from stem cells helped ease heart problems in monkeys and a human patient, in a potential advance ...

Fate Therapeutics uses iPSC and gene editing to offer scalable off-the-shelf therapies. Read more to see why I rate FATE ...

A new biological patch, designed from heart cells grown in the laboratory, could bring a glimmer of hope in the treatment of ...

该研究也指出，由于DMD突变类型多样且分布广泛，单一ASO药物难以覆盖所有患者。尤其是针对深层内含子突变的修复，现有方法的效果仍然有限。此外，基因治疗的研发成本高昂，临床转化周期长，给患者的普及使用带来显著障碍。

A woman with heart failure was kept alive long enough to receive a heart transplant, in part thanks to newly developed ...

This is especially problematic in cases of blocked blood vessels, which can repeatedly starve large areas of the heart of ...

In "remarkable" work, a patch of engineered heart muscle cells was used to strengthen a patient's heart before transplant.

AI’s endless adaptability forces us to rethink creativity and partner with tech in the age of digital alchemy.

Innovative muscle patches derived from stem cells demonstrate efficacy in heart repair, improving function in primates and a ...